In addition, HB-19 treatment inhibited in vivo angiogenesis in chick embryo chorioallantoic membrane assay, so the results indicate that surface nucleolin itself is also a target for cancer treatment (Destouches et al. 2008). The gene discussed is NUCLEOLIN; the disease is cancer.